Compare INFU & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INFU | PMI |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.8M | 202.7M |
| IPO Year | 2005 | N/A |
| Metric | INFU | PMI |
|---|---|---|
| Price | $10.65 | $0.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 80.1K | ★ 128.1K |
| Earning Date | 05-07-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $143,436,000.00 | N/A |
| Revenue This Year | $3.20 | N/A |
| Revenue Next Year | $7.31 | N/A |
| P/E Ratio | $33.32 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $4.66 | $0.81 |
| 52 Week High | $11.04 | $13.68 |
| Indicator | INFU | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 27.72 |
| Support Level | $8.52 | N/A |
| Resistance Level | $10.84 | $1.37 |
| Average True Range (ATR) | 0.39 | 0.06 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 78.32 | 4.52 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.